L'accès aux médicaments: Information en matière de brevets et liberté d’exploitation

haut de page

Nouvelles  

• 18 février 2011: Comment savoir si un médicament est déjà breveté? Un symposium se penche sur la question

• 21 janvier 2011: Deuxième symposium technique conjoint OMS — OMPI — OMC sur les brevets et l’accès aux médicaments

• 16 juillet 2010: L'OMS, l'OMPI et l'OMC unissent leurs efforts pour examiner l'accès aux médicaments au microscope
  
       

Résumé

• Télécharger en format pdf

 

haut de page

Programme et exposés   
(en anglais uniquement)

09h00–09h30 — Opening Remarks:

• Margaret Chan, Director-General, World Health Organization (WHO): remarks
   
  
• Francis Gurry, Director General, World Intellectual Property Organization (WIPO)
   
  
• Pascal Lamy, Director-General, World Trade Organization (WTO): remarks

> Video on WHO website: DG opening speeches
 

09h30–10h45 — Session 1: Access to medicines, patent information and freedom to operate — the context

• Access and information needs from a public health perspective
  Speaker: Zafar Mirza, WHO
  > Presentation
   
  

• Linking empirical data to policy processes: strengthening the base for policymaking on access to medicines
  Speaker: Antony Taubman, WTO
  > Presentation
   
  

• Managing intellectual property for access
  Speaker: Anatole Krattiger, WIPO
  > Presentation
  
  Discussion
  Moderator: Hans Hogerzeil, WHO

> Video on WHO website: Session 1

10h45–11h15 Break

11h15–13h00 — Session 2: Patent information and freedom to operate:
Methodologies and sources of information — case studies

• The patent status of medicines on the WHO model list for essential medicines
  Speaker: Stanley Kowalski University of New Hampshire — School of Law
  > Presentation
  
  Comments: Richard Laing, WHO
  > Presentation
  
  

• Understanding the patent status of Antiretroviral Drugs — a Medicines Patent Pool/WIPO collaboration
  Speaker: Ellen 't Hoen, Medicines Patent Pool
  > Presentation
   

• Global patent landscape on patenting activities in the field of vaccines
  Martin Friede, WHO
  > Presentation
    

• A freedom to operate analysis of dengue vaccines
  The comparative role of IP in achieving access
  Speaker: Richard Mahoney, International Vaccines Institute
  > Presentation
  
  Discussion
  Moderator: Konji Sebati, WIPO

> Video on WHO website: Session 2

13h00–14h30 Lunch Break

14h30–16h00 — Session 3: Practicalities of patent information use — gaps and needs

• Overview of patent information resources: WIPO experiences on legal status information
  Speaker: Lutz Mailänder, WIPO
  > Presentation

 

• Access to medicines: patent information in pharmaceutical procurement
  Speaker: Sophie Logez, The Global Fund to Fight AIDS,
  Tuberculosis and Malaria
  > Presentation

 

• Using patent information in managing practical access scenarios
  Speaker: Tahir Amin, Intellectual Property Initiative for Medicines, Access & Knowledge (I-MAK)
  > Presentation

 
Discussion
Moderator: Mathias Schaeli, Swiss Federal Institute of Intellectual
Property

> Video on WHO website: Session 3
  

16h00–16h30 Break

16h30–17h45 — Session 4: Panel Discussion: Strengthening the information base for access to medicine strategies — taking stock of experience and charting future directions

Panellists

• Rajiv I. Modi, Cadila Pharmaceuticals Ltd.
    

• Eric Notegen, IFPMA / F. Hoffmann-La Roche Ltd.
    

• Gitanjali Sakhuja, UNICEF
    

• John Kabare, African Regional Intellectual Property Organization (ARIPO)
  
  Moderators: Anatole Krattiger, WIPO, and Antony Taubman, WTO

> Video on WHO website: Session 4
  

17h45–18h00 — Closing Session

• Speaker: Marie-Paule Kieny, WHO
   
  Moderator: Johannes Christian Wichard, WIPO

> Video on WHO website: Closing session